FDA Accepts Shionogi’s sNDA for Fetroja in Pediatric Gram-Negative Infections
FLORHAM PARK, N.J., July 16, 2026 Shionogi Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...
complicated urinary tract infection
Advertisement
Basilea Lands New BARDA Funding for Resistant UTI Antibiotic
ALLSCHWIL, Switzerland — May 28, 2026 Basilea Pharmaceutica announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA),...
Meiji Seika Reports Positive Phase III Nacubactam Data
TOKYO, Japan, May 15, 2026 Meiji Seika Pharma Co., Ltd. announced that positive results from the global Phase III...
Advertisement
